Kong Liang, Bao Yongming, Yu Zhiyuan, Li Wei, Chen Xueguo, Hu Lianghai, Zou Hanfa
Dalian Institute of Chemical Physics, The Chinese Academy of Sciences, Dalian 116023, China.
Se Pu. 2005 Sep;23(5):470-6.
A new strategy for screening of antineoplastic components in the traditional Chinese medicine of Radix et Rhizoma Rhei has been developed using chromatographic fingerprints before and after metabolism by high performance liquid chromatography-mass spectrometry. The metabolizing method was established based on the in vitro metabolism by Sprague-Dawley (SD) rat liver homogenate. By means of the metabolism methods in vitro, the antineoplastic activity of the extracts, metabolites and components of Radix et Rhizoma Rhei were determined by microculture tetrazolium (MTT) assays in vitro. It was observed that the inhibition rate of the crude extract for HeLa cell was increased from 26.7% to 36.2% after 60 min of metabolism. The changes of activities resulted from the changes of components' structures and the bioactive components were discovered simultaneously in view of metabolism by inhibiting rate assay for the components in Radix et Rhizoma Rhei. It is concluded that the antineoplastic activity of the crude extract from Radix et Rhizoma Rhei was increased after in vitro metabolism because the antineoplastic activity of aloe-emodin, the metabolite of chrysophanol, is higher than its parent compounds.
利用高效液相色谱-质谱联用技术,通过对大黄生药代谢前后的色谱指纹图谱分析,建立了一种筛选大黄抗肿瘤活性成分的新策略。代谢方法基于SD大鼠肝匀浆体外代谢建立。采用体外代谢方法,通过MTT法体外测定大黄提取物、代谢产物及各成分的抗肿瘤活性。结果表明,代谢60 min后,大黄粗提物对HeLa细胞的抑制率从26.7%提高到36.2%。通过对大黄各成分抑制率的测定,从代谢角度发现活性变化是由成分结构改变引起的,同时发现了生物活性成分。研究得出结论,大黄粗提物体外代谢后抗肿瘤活性增强,是因为大黄酚的代谢产物芦荟大黄素的抗肿瘤活性高于其母体化合物。